Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Christopoulos

Showing results (1-10 of 331) with videos related to

Pageof 34
Sort By:
Trends in Pharmacological Sciences|December 3, 2014
Interview with Arthur ChristopoulosArthur Christopoulos
Molecular Pharmacology|July 26, 2014
Advances in G protein-coupled receptor allostery: from function to structureArthur Christopoulos
Nature Reviews. Drug Discovery|July 18, 2002
Allosteric binding sites on cell-surface receptors: novel targets for drug discoveryArthur Christopoulos
Pharmacological Reviews|May 31, 2002
G protein-coupled receptor allosterism and complexingArthur Christopoulos, Terry Kenakin
Nature Reviews. Drug Discovery|May 18, 2013
Measurements of ligand bias and functional affinityTerry Kenakin, Arthur Christopoulos
Nature Reviews. Drug Discovery|February 16, 2013
Signalling bias in new drug discovery: detection, quantification and therapeutic impactTerry Kenakin, Arthur Christopoulos
Trends in Pharmacological Sciences|March 15, 2011
Analytical pharmacology: the impact of numbers on pharmacologyTerry Kenakin, Arthur Christopoulos
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2003
Investigation of the interaction of a putative allosteric modulator, N-(2,3-diphenyl-1,2,4-thiadiazole-5-(2H)-ylidene) methanamine hydrobromide (SCH-202676), with M1 muscarinic acetylcholine receptorsAlfred Lanzafame, Arthur Christopoulos
British Journal of Pharmacology|February 28, 2013
Supra-physiological efficacy at GPCRs: superstition or super agonists?Christopher J Langmead, Arthur Christopoulos
Current Opinion in Cell Biology|April 1, 2014
Functional and structural perspectives on allosteric modulation of GPCRsChristopher J Langmead, Arthur Christopoulos
Pageof 34

Showing results (1-10 of 331) with videos related to

Sort By:
Pageof 34
Trends in Pharmacological Sciences|December 3, 2014
Interview with Arthur ChristopoulosArthur Christopoulos
Molecular Pharmacology|July 26, 2014
Advances in G protein-coupled receptor allostery: from function to structureArthur Christopoulos
Nature Reviews. Drug Discovery|July 18, 2002
Allosteric binding sites on cell-surface receptors: novel targets for drug discoveryArthur Christopoulos
Pharmacological Reviews|May 31, 2002
G protein-coupled receptor allosterism and complexingArthur Christopoulos, Terry Kenakin
Nature Reviews. Drug Discovery|May 18, 2013
Measurements of ligand bias and functional affinityTerry Kenakin, Arthur Christopoulos
Nature Reviews. Drug Discovery|February 16, 2013
Signalling bias in new drug discovery: detection, quantification and therapeutic impactTerry Kenakin, Arthur Christopoulos
Trends in Pharmacological Sciences|March 15, 2011
Analytical pharmacology: the impact of numbers on pharmacologyTerry Kenakin, Arthur Christopoulos
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2003
Investigation of the interaction of a putative allosteric modulator, N-(2,3-diphenyl-1,2,4-thiadiazole-5-(2H)-ylidene) methanamine hydrobromide (SCH-202676), with M1 muscarinic acetylcholine receptorsAlfred Lanzafame, Arthur Christopoulos
British Journal of Pharmacology|February 28, 2013
Supra-physiological efficacy at GPCRs: superstition or super agonists?Christopher J Langmead, Arthur Christopoulos
Current Opinion in Cell Biology|April 1, 2014
Functional and structural perspectives on allosteric modulation of GPCRsChristopher J Langmead, Arthur Christopoulos
Pageof 34